Cargando…

Tergitol-15-S-9 inactivates SARS-CoV-2 and boosts immunoassay signals

Inactivation of SARS-CoV-2 virus is necessary to mitigate risk but may interfere with diagnostic assay performance. We examined the effect of heat inactivation on a prototype SARS-CoV-2 antigen immunoassay run on the ARCHITECT automated analyzer. Recombinant full-length SARS-CoV-2 nucleocapsid prote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berg, Michael G, Israeli, Eitan, Quaco, Erin, Cloherty, Gavin A, Hemken, Philip M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Science Ltd 2021
Materias:	Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212844/ https://www.ncbi.nlm.nih.gov/pubmed/34139879 http://dx.doi.org/10.2144/btn-2021-0044

Ejemplares similares

Tergitol Based Decellularization Protocol Improves the Prerequisites for Pulmonary Xenografts: Characterization and Biocompatibility Assessment
por: Tondato, Susanna, et al.
Publicado: (2023)

Immunoassay-Compatible Inactivation of SARS-CoV-2 in Plasma Samples for Enhanced Handling Safety
por: Liew, Oi Wah, et al.
Publicado: (2022)

A New Decellularization Protocol of Porcine Aortic Valves Using Tergitol to Characterize the Scaffold with the Biocompatibility Profile Using Human Bone Marrow Mesenchymal Stem Cells
por: Faggioli, Marika, et al.
Publicado: (2022)

Inactivated and Immunogenic SARS-CoV-2 for Safe Use in Immunoassays and as an Immunization Control for Non-Clinical Trials
por: Gomes, Mariana Pierre de Barros, et al.
Publicado: (2023)

Comment on Manna et al. SARS-CoV-2 Inactivation in Aerosol by Means of Radiated Microwaves. Viruses 2023, 15, 1443
por: Taylor, Gavin J., et al.
Publicado: (2023)

Lateral Flow Immunoassays for SARS-CoV-2
por: Ang, Geik Yong, et al.
Publicado: (2022)

Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine
por: Zhang, Jialu, et al.
Publicado: (2021)

A two-arm analysis of the immune response to heterologous boosting of inactivated SARS-CoV-2 vaccines
por: Nithichanon, Arnone, et al.
Publicado: (2023)

Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern
por: Yue, Lei, et al.
Publicado: (2021)

Lateral Flow Immunoassay of SARS-CoV-2 Antigen with SERS-Based Registration: Development and Comparison with Traditional Immunoassays
por: Serebrennikova, Kseniya V., et al.
Publicado: (2021)

Serological chemiluminescence immunoassay for the diagnosis of SARS‐CoV‐2 infection
por: Lijia, Shao, et al.
Publicado: (2020)

Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
por: Jääskeläinen, AJ, et al.
Publicado: (2020)

Immunoassays for anti-SARS-CoV-2 antibodies: recent insights
por: Van Elslande, Jan, et al.
Publicado: (2021)

Clinical evaluation of commercial automated SARS-CoV-2 immunoassays
por: Kittel, Maximilian, et al.
Publicado: (2021)

Electrochemical Capillary Driven Immunoassay for Detection of SARS-CoV-2
por: Clark, Kaylee M., et al.
Publicado: (2022)

The protective nasal boosting of a triple-RBD subunit vaccine against SARS-CoV-2 following inactivated virus vaccination
por: Yang, Jingyi, et al.
Publicado: (2023)

Early Diagnosis of Pathogen Infection by Cell-Based Activation Immunoassay
por: Bar-Haim, Erez, et al.
Publicado: (2019)

Development and analytical performance of a new ARCHITECT automated dipeptidyl peptidase-4 immunoassay
por: Hemken, Philip M., et al.
Publicado: (2017)

Methods to evaluate the impact of SARS-CoV-2 nucleocapsid mutations on antigen detection by rapid diagnostic tests
por: Tieman, Bryan C, et al.
Publicado: (2022)

Assessment of SARS-CoV-2 Mu Variant Emergence and Spread in Colombia
por: Hernandez-Ortiz, Juan, et al.
Publicado: (2022)

Inactivated vaccine for SARS-CoV-2
por: Risson, Emma
Publicado: (2020)

Validation of a commercially available SARS-CoV-2 serological immunoassay
por: Meyer, B., et al.
Publicado: (2020)

Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays
por: Weidner, Lisa, et al.
Publicado: (2020)

Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population
por: Ige, Fehintola, et al.
Publicado: (2021)

Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay
por: Riester, Elena, et al.
Publicado: (2021)

Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
por: Chapuy-Regaud, Sabine, et al.
Publicado: (2021)

Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 antigens
por: Baccani, Ilaria, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2
por: Cerino, Pellegrino, et al.
Publicado: (2021)

Intensified antibody response elicited by boost suggests immune memory in individuals administered two doses of SARS-CoV-2 inactivated vaccine
por: Liao, Yun, et al.
Publicado: (2021)

Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine
por: Lu, Changrui, et al.
Publicado: (2023)

Synthesizing Submicron Polyelectrolyte Capsules to Boost Enzyme Immobilization and Enhance Enzyme-Based Immunoassays
por: Shao, Yanna, et al.
Publicado: (2023)

The Principles of SARS-CoV-2 Intervariant Competition Are Exemplified in the Pre-Omicron Era of the Colombian Epidemic
por: Orf, Gregory S., et al.
Publicado: (2023)

Competitive Immunoassay of SARS-CoV-2 Using Pig Sera-Derived Anti-SARS-CoV-2 Antibodies
por: Bong, Ji-Hong, et al.
Publicado: (2021)

Chemiluminescence Immunoassay Based Serological Immunoassays for Detection of SARS-CoV-2 Neutralizing Antibodies in COVID-19 Convalescent Patients and Vaccinated Population
por: Yin, Qiangling, et al.
Publicado: (2021)

Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves’ disease
por: Sriphrapradang, Chutintorn
Publicado: (2021)

Heterologous Prime-boost of SARS-CoV-2 inactivated vaccine and mRNA BNT162b2 among Healthy Thai Adolescents
por: Puthanakit, Thanyawee, et al.
Publicado: (2022)

SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine
por: Anderson, Mark, et al.
Publicado: (2021)

Immunoassay of Hormones
por: Bondy, Philip K.
Publicado: (1962)

Clinical application of Chemiluminescence Microparticle Immunoassay for SARS-CoV-2 infection diagnosis
por: Liu, Wanbing, et al.
Publicado: (2020)

Head-to-head validation of six immunoassays for SARS-CoV-2 in hospitalized patients
por: Zonneveld, Rens, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u7f5edc0naklpc9u8uqkg374n5